Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drug-Related Side Effects and Adverse Reactions"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 16974
Tytuł:
Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10-year French vigilances retrospective study.
Autorzy:
Caré W; Paris Poison Control Center, Toxicology Federation (FeTox), Hôpital Fernand Widal, AP-HP, Paris, France.; Internal Medicine Department, Bégin Military Teaching Hospital, Saint-Mandé, France.; Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, Inserm, Paris, France.
Pinel S; Regional Pharmacovigilance Center, Hôpital Fernand Widal, AP-HP, Paris, France.
Dufayet L; Paris Poison Control Center, Toxicology Federation (FeTox), Hôpital Fernand Widal, AP-HP, Paris, France.; Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, Inserm, Paris, France.; Forensic Department, Hôpital Hôtel Dieu, AP-HP, Paris, France.; UFR de médecine, Université de Paris, Paris, France.
Langrand J; Paris Poison Control Center, Toxicology Federation (FeTox), Hôpital Fernand Widal, AP-HP, Paris, France.; Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, Inserm, Paris, France.
Micallef J; Clinical Pharmacology Department, Regional Pharmacovigilance Center, Assistance publique-Hôpitaux de Marseille, Marseille, France.; INSERM, UMR 1106, Marseille, France.; Université d'Aix-Marseille, Marseille, France.
Vodovar D; Paris Poison Control Center, Toxicology Federation (FeTox), Hôpital Fernand Widal, AP-HP, Paris, France.; Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Cité, Inserm, Paris, France.; UFR de médecine, Université de Paris, Paris, France.
Pokaż więcej
Źródło:
Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2023 Dec; Vol. 37 (6), pp. 1205-1217. Date of Electronic Publication: 2023 Jul 03.
Typ publikacji:
Journal Article
MeSH Terms:
Tramadol*/adverse effects
Pancreatitis*/chemically induced
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
Young Adult ; Humans ; Female ; Adult ; Male ; Analgesics, Opioid/adverse effects ; Retrospective Studies ; Acute Disease ; Adverse Drug Reaction Reporting Systems ; Codeine/adverse effects ; Databases, Factual ; Pharmacovigilance
Czasopismo naukowe
Szczegóły
Tytuł:
Adverse drug reactions in hospitals: population estimates for Portugal and the ICD-9-CM to ICD-10-CM crosswalk.
Autorzy:
Ascenção R; Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina, Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal. .
Nogueira P; Escola Nacional de Saúde Pública - Universidade Nova de Lisboa, Lisboa, Portugal.
Sampaio F; Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden.
Henriques A; Nursing Research, Innovation and Development Centre of Lisbon (CIDNUR), Nursing School of Lisbon, Lisboa, Portugal.
Costa A; Instituto de Saúde Ambiental (ISAMB), Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Nov 08; Vol. 23 (1), pp. 1222. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
International Classification of Diseases*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Male ; Female ; Young Adult ; Humans ; Aged ; Portugal/epidemiology ; Hospitals ; Databases, Factual
Czasopismo naukowe
Szczegóły
Tytuł:
Are we PREPAREd? Concerning the "PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study".
Autorzy:
De Carmo Campos A; Serviço de Medicina III. Hospital Pulido Valente. Centro Hospitalar Universitário de Lisboa Norte. Lisboa; Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis. Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA). Lisboa. Portugal.
Cardoso ML; Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis. Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA). Lisboa; BioISI, Instituto de Biossistemas e Ciências Integrativas. Faculdade de Ciências da Universidade de Lisboa. Lisboa. Portugal.
Vicente A; Departamento de Promoção da Saúde e Prevenção de Doenças Não Transmissíveis. Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA). Lisboa; BioISI, Instituto de Biossistemas e Ciências Integrativas. Faculdade de Ciências da Universidade de Lisboa. Lisboa. Portugal.
Pokaż więcej
Źródło:
Acta medica portuguesa [Acta Med Port] 2023 Oct 02; Vol. 36 (10), pp. 689-690. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Letter
MeSH Terms:
Pharmacogenetics*
Drug-Related Side Effects and Adverse Reactions*/genetics
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Humans
Opinia redakcyjna
Szczegóły
Tytuł:
Facial palsy induced by immune checkpoint blockade: A systematic analysis of clinical trials and a pharmacovigilance study of postmarketing data.
Autorzy:
Zhu J; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China.
Li J; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China.
Zheng Y; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China.
Gao S; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China; Guangdong Province Hospital for Occupational Disease Prevention and Treatment, PR China.
He Z; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China.
Qiu K; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China.
Yu X; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China. Electronic address: .
Wu J; Department of Pharmacy, Sun-Yat-Sen Memorial Hospital, Sun Yat-sen University, PR China; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, PR China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Dec; Vol. 125 (Pt B), pp. 111184. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article
MeSH Terms:
Facial Paralysis*/etiology
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Pharmacovigilance ; Immunotherapy/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
A meta-analysis assessing the prevalence of drug-drug interactions among hospitalized patients.
Autorzy:
Aksoy N; Department of Clinical Pharmacy, Faculty of Pharmacy, Altınbaş University, İstanbul, Turkey.
Ozturk N; Department of Clinical Pharmacy, Faculty of Pharmacy, Altınbaş University, İstanbul, Turkey.; Department of Clinical Pharmacy, Graduate School of Health Sciences, İstanbul Medipol University, İstanbul, Turkey.
Pokaż więcej
Źródło:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2023 Dec; Vol. 32 (12), pp. 1319-1330. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Meta-Analysis; Journal Article; Review
MeSH Terms:
Hospitalization*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
Humans ; Prevalence ; Drug Interactions ; Hospitals
Czasopismo naukowe
Szczegóły
Tytuł:
Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database.
Autorzy:
Klomjit N; Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Evans R; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Le TK; Department of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Wells SL; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ortega J; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Green-Lingren O; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Mazepa M; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Sise ME; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jhaveri KD; Division of Kidney Diseases and Hypertension, Donald and Barbara Zucker School of Medicine, Great Neck, New York, USA.
Gupta S; Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Adult Survivorship Program, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2023 Dec; Vol. 98 (12), pp. E369-E372. Date of Electronic Publication: 2023 Sep 23.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural
MeSH Terms:
Thrombotic Microangiopathies*/chemically induced
Thrombotic Microangiopathies*/epidemiology
Antineoplastic Agents*/adverse effects
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
Humans ; Pharmacovigilance ; Bayes Theorem
Raport
Szczegóły
Tytuł:
Moving toward a contemporary classification of drug-induced kidney disease.
Autorzy:
Karimzadeh I; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Barreto EF; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
Kellum JA; Department of Critical Care Medicine, Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Awdishu L; Division of Clinical Pharmacy, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, La Jolla, CA, USA.
Murray PT; School of Medicine, University College Dublin, Dublin, Ireland.
Ostermann M; Department of Intensive Care, King's College London, Guy's and St Thomas' Hospital, London, UK.
Bihorac A; Department of Medicine, University of Florida, Gainesville, FL, USA.; Intelligent Critical Care Center, University of Florida, Gainesville, FL, USA.
Mehta RL; Department of Medicine, University of California, San Diego, CA, USA.
Goldstein SL; Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Kashani KB; Division of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Kane-Gill SL; Department of Critical Care Medicine, Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. .; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA. .; Department of Pharmacy, UPMC, Pittsburgh, PA, USA. .; Department of Critical Care Medicine, Department of Biomedical Informatics, School of Medicine and the Clinical Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA. .
Pokaż więcej
Źródło:
Critical care (London, England) [Crit Care] 2023 Nov 09; Vol. 27 (1), pp. 435. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/diagnosis
Drug-Related Side Effects and Adverse Reactions*
Humans ; Biomarkers ; Critical Illness ; Consensus
Czasopismo naukowe
Szczegóły
Tytuł:
Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
Autorzy:
Cragg A; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Small SS; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Lau E; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada.
Rowe A; Emergency Department, University Health Network, Toronto, ON, Canada.
Lau A; Emergency Department, Vancouver General Hospital, Vancouver, BC, Canada.
Butcher K; Emergency Department, Vancouver General Hospital, Vancouver, BC, Canada.
Hohl CM; Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada. .; Emergency Department, Vancouver General Hospital, Vancouver, BC, Canada. .
Pokaż więcej
Źródło:
Drug safety [Drug Saf] 2023 Nov; Vol. 46 (11), pp. 1161-1172. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Observational Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adverse Drug Reaction Reporting Systems*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Male ; Female ; Humans ; Pharmacists ; Hospitals ; Hospitalization
Czasopismo naukowe
Szczegóły
Tytuł:
Development and Application of a Data-Driven Signal Detection Method for Surveillance of Adverse Event Variability Across Manufacturing Lots of Biologics.
Autorzy:
Wilde JT; Massachusetts Institute of Technology, Operations Research Center, Cambridge, MA, USA.
Springs S; Massachusetts Institute of Technology, Center for Biomedical Innovation, Cambridge, MA, USA.
Wolfrum JM; Massachusetts Institute of Technology, Center for Biomedical Innovation, Cambridge, MA, USA.
Levi R; Massachusetts Institute of Technology, Sloan School of Management, Building E62, 100 Main Street, Cambridge, MA, 02142, USA. .
Pokaż więcej
Źródło:
Drug safety [Drug Saf] 2023 Nov; Vol. 46 (11), pp. 1117-1131. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Biological Products*/adverse effects
Drug-Related Side Effects and Adverse Reactions*/diagnosis
Drug-Related Side Effects and Adverse Reactions*/epidemiology
United States ; Humans ; Adverse Drug Reaction Reporting Systems ; Product Surveillance, Postmarketing/methods ; United States Food and Drug Administration ; Research Design
Czasopismo naukowe
Szczegóły
Tytuł:
Systematic Review and Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults: An Update.
Autorzy:
Gray SL; Department of Pharmacy, School of Pharmacy, University of Washington, Health Sciences Building, H-361D, Box 357630, Seattle, WA, 98195-7630, USA. .
Perera S; Department of Medicine (Geriatrics), School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Biostatistics, School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Soverns T; Department of Pharmacy, School of Pharmacy, University of Washington, Health Sciences Building, H-361D, Box 357630, Seattle, WA, 98195-7630, USA.
Hanlon JT; Department of Medicine (Geriatrics), School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Geriatric Research, Education, and Clinical Center, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA.; Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Pokaż więcej
Źródło:
Drugs & aging [Drugs Aging] 2023 Nov; Vol. 40 (11), pp. 965-979. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Meta-Analysis; Systematic Review; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Humans ; Aged
Raport
Szczegóły
Tytuł:
Movement disorders associated with antiseizure medications: A real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.
Autorzy:
Zhou J; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Medical University, Fuzhou, Fujian, China.
Wei Z; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Medical University, Fuzhou, Fujian, China.
Chen S; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Medical University, Fuzhou, Fujian, China.
Xie H; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Huang W; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Medical University, Fuzhou, Fujian, China.
Liu M; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Medical University, Fuzhou, Fujian, China.
Wu X; School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.; Fujian Medical University, Fuzhou, Fujian, China.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Nov; Vol. 89 (11), pp. 3389-3400. Date of Electronic Publication: 2023 Jul 18.
Typ publikacji:
Journal Article
MeSH Terms:
Movement Disorders*/epidemiology
Movement Disorders*/etiology
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/etiology
United States ; Female ; Male ; Humans ; Quality of Life ; United States Food and Drug Administration ; Benzodiazepines ; Anticonvulsants/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
Suitability of indexing terms in the MEDLINE bibliographic database on drug-related problems.
Autorzy:
Martínez-Aguilar L; Pharmaceutical Research Group of the University of Granada, Faculty of Pharmacy, University of Granada, Granada, Spain.
Sanz-Valero J; Carlos III Health Institute, National School of Occupational Medicine, Madrid, Spain. Electronic address: .
Martínez-Martínez F; Pharmaceutical Research Group of the University of Granada, Faculty of Pharmacy, University of Granada, Granada, Spain.
Faus MJ; Pharmaceutical Research Group of the University of Granada, Faculty of Pharmacy, University of Granada, Granada, Spain.
Pokaż więcej
Źródło:
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2023 Nov; Vol. 19 (11), pp. 1440-1445. Date of Electronic Publication: 2023 Jul 19.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Overdose*
Drug-Related Side Effects and Adverse Reactions*
Humans ; MEDLINE ; Databases, Bibliographic ; Databases, Factual
Czasopismo naukowe
Szczegóły
Tytuł:
Alleviative effect of melatonin against the nephrotoxicity induced by cadmium exposure through regulating renal oxidative stress, inflammatory reaction, and fibrosis in a mouse model.
Autorzy:
Yang Z; School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China. Electronic address: .
He Y; School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China.
Ma Q; School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China.
Wang H; School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China.
Zhang Q; School of Life Science and Technology, Gansu Agricultural University, Lanzhou 730070, China.
Pokaż więcej
Źródło:
Ecotoxicology and environmental safety [Ecotoxicol Environ Saf] 2023 Oct 15; Vol. 265, pp. 115536. Date of Electronic Publication: 2023 Oct 03.
Typ publikacji:
Journal Article
MeSH Terms:
Melatonin*/pharmacology
Melatonin*/therapeutic use
Melatonin*/metabolism
Drug-Related Side Effects and Adverse Reactions*/metabolism
Drug-Related Side Effects and Adverse Reactions*/pathology
Humans ; Male ; Mice ; Animals ; Cadmium/metabolism ; Mice, Inbred C57BL ; Kidney ; Oxidative Stress ; Inflammation/chemically induced ; Inflammation/drug therapy ; Inflammation/metabolism ; Fibrosis
Czasopismo naukowe
Szczegóły
Tytuł:
A Multi-method Exploratory Evaluation of a Service Designed to Improve Medication Safety for Patients with Monitored Dosage Systems Following Hospital Discharge.
Autorzy:
Alqenae FA; Division of Pharmacy and Optometry, School of Health Sciences, Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Oxford Road, Manchester, M13 9PT, UK. .
Steinke D; Division of Pharmacy and Optometry, School of Health Sciences, Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Belither H; Pharmacy Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, Greater Manchester, UK.
Robertson P; Primary Care Practice, Salford, Manchester, UK.
Bartlett J; Pharmacy Department, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, Greater Manchester, UK.
Wilkinson J; Centre for Biostatistics, Division of Population Health, Health Service Research and Primary Care, School of Health Sciences, University of Manchester, Manchester, UK.
Williams SD; Division of Pharmacy and Optometry, School of Health Sciences, Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.; Westbourne Medical Centre, Bournemouth, UK.
Brad L; Westbourne Medical Centre, Bournemouth, UK.
Jeffries M; Division of Pharmacy and Optometry, School of Health Sciences, Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.; NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester, UK.; Division of Population Health, Health Service Research & Primary Care, School of Health Sciences, University of Manchester, Manchester, UK.
Ashcroft DM; Division of Pharmacy and Optometry, School of Health Sciences, Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.; NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester, UK.
Keers RN; Division of Pharmacy and Optometry, School of Health Sciences, Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.; NIHR Greater Manchester Patient Safety Translational Research Centre, Manchester, UK.; Suicide, Risk and Safety Research Unit, Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.
Pokaż więcej
Źródło:
Drug safety [Drug Saf] 2023 Oct; Vol. 46 (10), pp. 1021-1037. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Pharmacy Service, Hospital*
Humans ; Patient Discharge ; Medication Reconciliation/methods ; Retrospective Studies ; State Medicine ; Hospitals ; Pharmacists
Czasopismo naukowe
Szczegóły
Tytuł:
Toxicity and Adverse Effects in Clozapine-Related Presentations to a Medical Toxicology Service in Western Sydney.
Autorzy:
Chandru P; Department of Clinical Pharmacology & Toxicology, Western Sydney Health, Sydney, Australia. .
Gunja N; Department of Clinical Pharmacology & Toxicology, Western Sydney Health, Sydney, Australia.; Discipline of Emergency Medicine, Sydney Medical School, University of Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Journal of medical toxicology : official journal of the American College of Medical Toxicology [J Med Toxicol] 2023 Oct; Vol. 19 (4), pp. 374-380. Date of Electronic Publication: 2023 Aug 25.
Typ publikacji:
Journal Article
MeSH Terms:
Antipsychotic Agents*/toxicity
Clozapine*/toxicity
Drug-Related Side Effects and Adverse Reactions*/diagnosis
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Drug-Related Side Effects and Adverse Reactions*/drug therapy
Humans ; Hypnotics and Sedatives ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
Drug shortages. Part 1. Definitions and harms.
Autorzy:
Aronson JK; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK.
Heneghan C; Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK.
Ferner RE; West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK.; School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Oct; Vol. 89 (10), pp. 2950-2956. Date of Electronic Publication: 2023 Aug 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Medication Errors*
Drug-Related Side Effects and Adverse Reactions*/etiology
Drug-Related Side Effects and Adverse Reactions*/prevention & control
Humans ; Pharmaceutical Preparations
Czasopismo naukowe
Szczegóły
Tytuł:
The safety of rush immunotherapy in the management of canine atopic dermatitis-230 cases.
Autorzy:
Weitzer T; Center for Clinical Veterinary Medicine, LMU Munich, Munich, Germany.
Mueller R; Center for Clinical Veterinary Medicine, LMU Munich, Munich, Germany.
Pokaż więcej
Źródło:
Veterinary dermatology [Vet Dermatol] 2023 Oct; Vol. 34 (5), pp. 385-392. Date of Electronic Publication: 2023 May 08.
Typ publikacji:
Journal Article
MeSH Terms:
Dermatitis, Atopic*/veterinary
Dermatitis, Atopic*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/drug therapy
Drug-Related Side Effects and Adverse Reactions*/etiology
Drug-Related Side Effects and Adverse Reactions*/veterinary
Dog Diseases*/drug therapy
Dogs ; Animals ; Retrospective Studies ; Injections, Subcutaneous/veterinary ; Immunotherapy/adverse effects ; Immunotherapy/veterinary ; Immunotherapy/methods ; Allergens/adverse effects ; Desensitization, Immunologic/adverse effects ; Desensitization, Immunologic/veterinary ; Desensitization, Immunologic/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Post-marketing surveillance study of the safety of the HPV-16/18 vaccine in Korea (2017-2021).
Autorzy:
Eun BW; Nowon Eulji University Hospital, Seoul, Republic of Korea.
Bahar E; GSK, Wavre, Belgium.
Xavier S; GSK, Bengaluru, India.
Kim H; GSK, Seoul, Republic of Korea.
Borys D; GSK, Wavre, Belgium.
Pokaż więcej
Źródło:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2184756. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Uterine Cervical Neoplasms*/prevention & control
Papillomavirus Infections*
Papillomavirus Vaccines*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Male ; Female ; Humans ; Child ; Adolescent ; Young Adult ; Adult ; Human papillomavirus 16 ; Human papillomavirus 18 ; Injection Site Reaction ; Product Surveillance, Postmarketing ; Republic of Korea
Czasopismo naukowe
Szczegóły
Tytuł:
Adverse events of epidiolex: A real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database.
Autorzy:
Zhou Q; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China.
Du Z; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China.
Qu K; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China.
Shen Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China.
Jiang Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China. Electronic address: .
Zhu H; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu 214151, China. Electronic address: .
Zhang X; Department of Pharmacy, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, China. Electronic address: .
Pokaż więcej
Źródło:
Asian journal of psychiatry [Asian J Psychiatr] 2023 Dec; Vol. 90, pp. 103828. Date of Electronic Publication: 2023 Nov 04.
Typ publikacji:
Journal Article
MeSH Terms:
Cannabidiol*
Drug-Related Side Effects and Adverse Reactions*
United States/epidemiology ; Humans ; Adverse Drug Reaction Reporting Systems ; United States Food and Drug Administration ; Software
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of prophylactic dexamethasone on the efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy in patients with advanced Non-Squamous Non-Small-Cell lung cancer.
Autorzy:
Yu H; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
Chen J; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.
Zhou Y; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
Sheng J; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Zhejiang 310018, Hangzhou, China.
Zhang X; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
He L; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
Chen L; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China.
Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: .
Zhang L; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. Electronic address: .
Hong S; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, China; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong 510060, China; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2023 Dec; Vol. 125 (Pt B), pp. 111138. Date of Electronic Publication: 2023 Nov 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Drug-Related Side Effects and Adverse Reactions*
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Programmed Cell Death 1 Receptor ; Retrospective Studies ; Dexamethasone/therapeutic use
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 16974

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies